£685 / $1095 / €820
A business publication for tracking autoimmune developments worldwide
Do you want to keep up to date with all the latest developments in this important and high-value pharmaceutical area? Autoimmune Drug Focus (ADF) provides a simple, time-saving way to do just that. It summarises all the latest developments in an easy-to-read format, providing company and compound indexes. Can you afford to be without it?
With approximately 4% of the population suffering from an autoimmune disease and with the prevalence of these disorders rising, it is unsurprising that each year, millions of dollars are devoted to researching the causes of autoimmune disorders.
Regular sections in ADF include:
We spend the time and effort monitoring the market so you don't have to!
ADF is available in email and web formats. The web version of ADF provides you with a regularly updated news service, while the pdf issues provide a monthly digest (12 issues per year).
Cost-effective multi-user distribution deals means the service can be used widely by colleagues in your organisation – contact sales at firstname.lastname@example.org for details, alternatively you can use our contact us page.